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Collective Syntheses of Icetexane Natural Products Based on 
Biogenetic Hypotheses 
 
Christophe Thommen,[a],[b] Markus Neuburger, [b] and Karl Gademann*[a], [b] 
 
Abstract: A divergent synthesis of ten members of icetexane natural 
products based on a proposed biogenetic cationic ring expansion of 
a reduced carnosic acid derivative is described. Among these 
members, (+)-salvicanol, (−)-cyclocoulterone, (−)-coulterone, 
(−)-obtusinone D and (−)-obtusinone E have been synthesized for 
the first time. In addition, the hypothesis for the non-enzymatic 
biogenesis of benzo[1,3]dioxole natural products has been further 
experimentally investigated. Additional experimental evidence for the 
abiotic formation of the methylenedioxy unit is provided, as 
photolysis of the quinone (+)-komaroviquinone resulted in the 
formation of the [1,3]dioxole-containing natural product 
(−)-cyclocoulterone and of (+)-komarovispirone. 
Introduction 
Terpenes display an extraordinary wealth of fascinating 
chemical structures, which provided inspiration for chemists over 
decades.[1] The understanding and development of cyclization 
reaction cascades[2], cationic rearrangements[3] or the 
mechanism of C–H oxidation[4] greatly influenced science, from 
reaction mechanisms to biosynthesis. The methylenedioxy 
bridged phenol unit (benzo[1,3]dioxole) is frequently found in 
many compounds,[5] including commercially important 
compounds such as the fragrances piperonal and helional®, or 
drugs such as ecteinascidin 743 or etoposide (Figure 1). 
Consequently, the biosynthesis of this important moiety has 
been investigated for decades via chemical, enzymatic and 
genetic approaches. [6] 
 
 
Figure 1. Terpenoids featuring the benzo[1,3]dioxole unit, including those with 
commercial interest.  
 
In a landmark study published in 1962, Sir Derek Barton 
reported experimental evidence that the origin of the 
benzo[1,3]dioxole unit found in the alkaloid haemanthamine 
resides in a monomethyl-catechol unit, and he postulated that 
this transformation proceeds via an oxidative process. [7] This 
hypothesis has been substantiated by many experiments, and in 
recent years, the involvement of cytochrome P450 enzymes in 
the oxidative cyclization has been unequivocally demonstrated 
for several natural products[6] (Scheme 1, top). In the context of 
taiwaniaquinol A, we have previously identified an alternative 
pathway to benzo[1,3]dioxole formation that is (a) redox neutral, 
(b) light mediated, and most importantly (c) without the 
involvement of any enzymes (Scheme 1, bottom). [8] 
 
 
Scheme 1. Biogenesis of benzo[1,3]dioxole natural products. 
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In this study, we present (1) evidence further corroborating this 
abiotic hypothesis via the preparation of two benzo[1,3]dioxole 
natural products in the chemical laboratory, and describe a 
model study aimed at elucidating mechanistic details. In addition, 
we investigated potential routes for the biogenesis of icetexane 
terpenes, and provide (2) the first experimental evidence for the 
abiotic formation of the tertiary OH group during the ring 
expansion from the abietane to the icetexane family.  Finally, (3) 
the abiotic formation of the complex C40 dimers, obtusinone D 
and E is reported, and their configuration is reassigned. Overall, 
the first preparation in synthetic form of five natural products is 
reported, i.e. (+)-salvicanol, (–)-cyclocoulterone, (–)-coulterone, 
(–)-obtusinone D and (−)-obtusinone E, and alternative 
approaches for the preparation of komaroviquinone, 
komarovispirone, brussonol, przewalskin E and 
demethylsalvicanol quionone are presented in this publication. 
 
 
Scheme 2. Remote C–H functionalization of taiwaniaquinone F and 
komaroviquinone. 
 
In our previous study, we reported the photolysis of 
taiwaniaquinone F to taiwaniaquinol A (Scheme 2, A). [8] We 
proposed a hypothesis where such a methylenedioxy bridge 
bearing a 1,2,4-hydroxylated aryl moiety can be biosynthetically 
generated via a light promoted remote C−H activation. 
Regarding the biosynthesis of this structural unit, this postulate 
would be complementary to the well-accepted and established 
cytochrome P450 mechanism[6] to produce the methylenedioxy 
bridge, especially in the plant kingdom where the use of light as 
a source of energy is omnipresent. Therefore, the first goal of 
this study consisted in demonstrating that the previously 
discovered photolysis of taiwaniaquinone F can also be applied 
to additional substrates in order to emphasize the generality of 
this transformation in Nature. Therefore, we proposed that the 
complex benzo[1,3]dioxole derivative cyclocoulterone (1) [9] 
(Scheme 2, B) could be generated from komaroviquinone (2) [9] 
via such an abiotic ring formation reaction as postulated above. 
In support of the biogenetic hypothesis of this transformation, 
both cyclocoulterone (1) and komaroviquinone (2) were isolated 
from the same plant (Dracocephalum komarovi), corroborating a 
possible biogenetic connection between both natural products. [9] 
A previous report of Majetich and co-workers describes the 
photolysis of komaroviquinone (2) in cyclohexane, which 
furnished komarovispirone (3) in high yield.[10] However, these 
authors detected an unknown product in low yield, which 
however was not characterized at the time. We expected that 
the use of the conditions developed for the photolysis of 
taiwaniaquinone F would turn the course of the photolysis of 
komaroviquinone (2) in favor of the generation of 
cyclocoulterone (1). If successful, this abiotic, non-enzymatic 
transformation of komaroviquinone (2) to cyclocoulterone (1) 
would further substantiate the abiotic hypothesis of 
benzo[1,3]dioxoles. In order to test this hypothesis, first the 
icetexane precursor 2 had to be prepared in synthetic form. 
Results and Discussion 
Investigation of the Ring Expansion in Icetexane Biogenesis. 
Icetexanes constitute a variety of diterpenoids isolated from 
diverse plant sources, in particular from the Labiatae family. [11] 
These compounds exhibit a unique carbon skeleton consisting 
of a 6-7-6 tricyclic core structure (Figure 2). The systematic 
name 9(10→20)-abeo-abietane given to icetexanes indicates an 
abietane precursor such as 4 could be involved in biosynthetic 
origin of icetexanes (Scheme 3). To the best of our knowledge, 
Watson and 
 
 
 
Figure 2. Examples of icetexane natural products. [11] 
 
Dominguez were the first to propose such a connection between 
abietanes and icetexanes,[12] but several other research 
laboratories have proposed similar mechanisms to connect 
abietanes to their rearranged congeners. [13] Hydride abstraction 
from the angular methyl group (X = H) or solvolysis of the 
primary alcohol (X = OH) of abietane 4 generates a primary 
cation that could immediately rearrange to the more stable ring 
expanded tertiary carbocation 5 forming the icetexane core 
structure. Ring expansions which lead to alkenes 6 via a 
deprotonation of carbocation 5 were experimentally supported. 
[14] Indeed, such rearrangements were performed by treating 
primary hydroxyl abietanes such as 4 with either thionyl chloride 
in dry benzene or p-TsCl in dry pyridine to yield alkene 
icetexanes such as 6. [14] Although trapping of carbocation 5 by a 
water molecule was frequently suggested to access icetexanes 
bearing a C10 hydroxyl group such as in alcohol 7, no 
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experimental evidence of such a mechanism was reported. [13] In 
this study, we provide the first experimental evidence which is 
supporting this transformation. In particular, we demonstrate that 
no enzymes are necessary for the attack on the b-face. 
 
 
 
Scheme 3. Hypothetical biogenetic abietane ring expansion to icetexanes. X = 
H or OH. 
 
The synthesis started with carnosic acid, a commercially 
available and naturally abundant abietane. [15] Carnosic acid is 
found in significant amount in Lamiaceae and particularly in 
Rosmarinus officinalis and Salvia officinalis. The content of 
carnosic acid in the dried leaves is varying in proportion from 1% 
to 10% (by weight), depending on the species, the plant age and 
the environmental stress. [16] The extraction, purification and 
isolation of carnosic acid was achieved by HPLC from crushed 
and dried leaves of rosemary (Rosmarinus officinalis, origin: 
Portugal) as reported by Albu et al. [17] However, the triple 
methylation of pure carnosic acid using the modified conditions 
of Theoduloz et al. resulted only in a moderate yield of 8 
(66%).[18] Encouraged by literature reports of related constituents 
of rosemary, we changed our strategy in order to obtain higher 
quantities of ester 8. [17], [19] In this regard, the dried ethanolic 
extract of rosemary was dissolved in Et2O and extracted with 
NaOH (1 M) in order to form the aqueous soluble sodium salts of 
different phenols. Acidification (1 M aq. HCl) and ethereal 
extraction of the aqueous phase yielded an phenolic abietane 
enriched extract, which was subjected to the exhaustive 
methylation (NaH, Me2SO4, THF, then MeOH) to yield a mixture 
of the desired trimethylated carnosic acid 8 and by-products. 
The mixture was further refined by dissolving the constituents in 
MeOH, filtration, and subsequent hydrogenation using Pd(OH)2 
/C resulted in pure dimethoxy canosiate methyl ester 8 (1.3 
weight% from dried and crushed rosemary). A smooth reduction 
of the angular methoxy ester group of 8 was achieved via a 
modified literature protocol using LAH in hot ether, which 
resulted in alcohol 9 in excellent yield (89%, Scheme 5). [20] 
 
 
 
Scheme 4. Isolation and derivatization of carnosic acid. 
 
Having the desired alcohol 9 in hand, we wanted to 
experimentally investigate the ring expansion hypothesis as 
outlined above in Scheme 3. To this end, the primary alcohol 9 
was treated with different acids in aqueous solution. Only strong 
acids were able to promote a ring expansion leading to an 
inseparable mixture of alkenes 10 in low yields. Furthermore, 
such harsh conditions prevented the formation of alcohol 11, 
probably due to direct elimination. Finally, basic treatment of 9  
(MsCl, Et3N in THF followed by addition of water) resulted in the 
tertiary alcohol 11 bearing the icetexane skeleton in 32% yield 
as a mixture with isomeric olefins 10 in an excellent overall yield 
of 94%. This remarkable transformation warrants a number of 
mechanistic comments. First, it is likely that the mesylate 
undergoes E1 elimination to generate the primary cation. As can 
be deduced from the product, a cation similar to 5 would have to 
be generated via an 1,2-alkyl shift. Alternatively, a concerted 
process merging these two steps could be operative. The next 
step now constitutes the key scientific problem, which has been 
debated in the literature for decades. [12], [13] The attack of water 
on such a carbocation was suggested to be disfavored from the 
β-face according to Dreiding models and therefore supporting an 
enzymatically guided attack.[21] However, our exclusively 
observed b-selectivity refutes this enzymatic hypothesis and 
thus establishes a non-enzymatic mechanism. [21] This ring 
expansion presents the first experimental study that invokes a 
water mediated trapping of a tertiary carbocation such as 5. This 
constitutes the first experimental confirmation that validates the 
biosynthetic hypothesis of icetexane bearing a C10 tertiary 
alcohol, shown earlier (Scheme 3).  
 
 
Scheme 5. Preparation of salvicanol (12) based on a biogenetic ring 
expansion hypothesis: a) LAH, Et2O, 45 °C, 6 h, 89%; b) MsCl, Et3N, THF, –
10 °C, 20 min; H2O, 40 °C, 12 h, 94%; c) L-Selectride solution in THF, 80 °C, 2 
h, 80%; d) (i) m-CPBA, CH2Cl2, 0 °C, 2 h; (ii) L-Selectride (excess) solution in 
THF, 80 °C, 3 h, 42% (2 steps); e) Ac2O, pyridine, rt, 1 h, 90%. 
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A selective hydride mediated demethylation (L-selectride in THF, 
80 °C, 2 h) originally developed by Majetich et al. was 
successfully applied to the tertiary alcohol 11.[22] Indeed, the 
sterically less congested C11 methoxy group was selectively 
demethylated with complete regioselectivity in high yield (80%), 
leading to the first synthesis of salvicanol (12). All spectroscopic 
data are in agreement with those reported for the natural sample. 
[23] The alkenes 10, obtained in the course of the ring expansion 
of 9, could be converted to salvicanol (12) in two consecutive 
steps consisting of an epoxidation carried out using m-CPBA[24] 
and a well-established one-pot hydride (L-selectride) mediated 
epoxide opening/demethylation in 42% yield over two steps. [25] 
Salvicanol (12) could also be acetylated in high yield (90%) to 
afford salvicanol acetate (13), which was used later on for the 
subsequent oxidation. [23]  
 
Experimental evidence for abiotic benzo[1,3]dioxole 
formation. 
 
Having the methyl and acetyl derivatives of salvicanol (11 and 
13, respectively), a C7 benzylic oxidation as well as an aromatic 
oxidation constituted the missing steps to accomplish the 
synthesis of komaroviquinone (2). Majetich and co-workers 
reported a difficult C7 benzylic oxidation of a substrate, which is 
very similar to 12 and 13. [26] They concluded that the C10 OH-
group would not tolerate oxidative conditions and result in a 
C10-C20 oxidative cleavage. These results could be reproduced 
with substrate 12 and 13 using similar conditions (CrO3, 
AcOH/H2O, Table 1, entry 1 and 2), giving rise to the unstable 
aldehydes 14 and 15, but only trace amounts were obtained. 
Further attempts involving the possible formation of benzylic 
radicals, such as the use of KBr in presence of Oxone® (entry 3) 
resulted in the formation of the side-product 16, presumably via 
the bromination with a Br+ species. [27] The transition metal free 
oxidation of 13 using TBHP under microwave conditions (180 °C, 
CH3CN, entry 4) resulted in trace amounts of the desired ketone 
17 (detected by 1H-NMR).  
The successful formation of 17 in presence of TBHP 
encouraged us to investigate different combinations of transition 
metal catalysts with TBHP (entries 5-12). Indeed, the formation 
of the desired product 17 was observed by utilizing several 
transition metals (entries 6-9, and 11-12). The optimal conditions 
were identified when reacting acetate 13 under a modified Hirao 
protocol (RuCl3xH2O, TBHP, entry 12).[28] The benzylic 
oxidation product 17 was obtained in moderate yield (31%) 
along with starting material (13, 19%). NMR analysis of this 
compound was difficult due to the keto-hemiketal tautomerism 
equilibrium between the open (17) and the closed form (18), as 
already observed on a similar hydroxy- ketone by Suto and co-
workers.[29] Conditions using transition metals without TBHP 
were also investigated (entries 13-16).[30] However, compounds 
19 (and 20, entry 16) or 17 (and 18, entries 13 and 15), were 
produced only in trace amounts. These experiments led to the 
identification of RuCl3/TBHP as optimal oxidant, which was used 
in the synthesis (Scheme 6). 
 
Table 1. Benzylic oxidation of the salvicanol derivatives. 
 
 
 
Entry Conditions Substrate Observations 
1 CrO3 11 14[a]  
2 CrO3 13 15[a] 
3 KBr, Oxone, DCM/H2O 11 16[a] 
4 TBHP, MW 13 17[a] 
5 Cr(CO)6, TBHP 11 No conversion 
6 Cr(CO)6, TBHP 13 17: 10% 
7 Rh2(cap)4, TBHP 13 17[a] 
8 Ru(Cl)2(PPh3)2, TBHP 13 17:10%, 13: 40% 
9 ReOCl3(OPPh3)(SMe)2, 
TBHP 
13 17[a] 
10 VCp2Cl2, TBHP 13 No conversion 
11 Bi(0), picolinic acid, 
TBHP 
13 17: 17%, 13: 13% 
12 RuCl3xH2O, TBHP 13 17: 31%, 13: 19%  
13 Fe(OTf)2, ligands, H2O2 13 17[a] 
14 NaIO4, RuCl3xH2O 13 Complex mixture 
15 KMnO4/CuSO45H2O 13 17[a] 
16 KMnO4/CuSO45H2O 11 19[a]  
 
[a] Observed in trace amounts. 
 
For the completion of the synthesis of komaroviquinone (2, 
Scheme 6), the ketone 17 was first deacetylated using KOH in 
methanol at rt for 12 h. The crude mixture was subsequently 
submitted to aromatic oxidation to phenol 21 using salcomine in 
an O2 atmosphere with strict exclusion from light to yield 
synthetic komaroviquinone (2) in 56% yield over two steps. This 
modest yield could be explained by the C7 keto group, which 
lowers the electron density of the aromatic ring and therefore 
decreases the reactivity towards oxidation. Furthermore, 
komaroviquinone (2) was obtained as the sole tautomer, which 
could be explained by the newly formed H-bond at the C14-keto 
group, and by the increased electrophilicity of the C7 vinylogous 
ketone compared to the benzylic ketone in structure 17. 
Next, the photolysis of komaroviquinone (2), applying similar 
conditions as used for the synthesis of taiwaniaquinol A (Et2O, 
sunlight, rt), was carried out. [8] We were delighted to observe the 
formation of the cyclocoulterone (1) as well as the known 
komarovispirone (3) in nearly equimolar ratio with an overall 
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yield of 63%. These findings further supported our previously 
non-enzymatic biogenetic hypothesis for the biosynthesis of 
such methylenedioxy bridge natural product. In addition, this 
experiment also yielded for the first time synthetic 
cyclocoulterone (1). 
Additionally, komaroviquinone 2 was reduced in an ethereal 
solution using an aqueous solution Na2S2O4 in a separatory 
funnel at rt for 1 min, which afforded coulterone (22) in high yield 
(82%). This natural product was isolated over 20 years ago, [31] 
but has so far never been synthesized. 
 
 
 
Scheme 6. Completion of the synthesis of komaroviquinone (2): a) RuCl3 . 
xH2O, CH2Cl2/Pyr, t-BuOOH, 50 °C, 12 h, 31%, 50% brsm; b) KOH, MeOH, rt, 
12 h; c) Salcomine, O2 (5 bar), MeCN, 12 h, 56% (2 steps); d) Sunlight, Et2O, 
4°C (winter), 45 min, 63%; e) Na2S2O4 (aq.), Et2O, 1 min. 
 
The previous photolysis of komaroviquinone (2), achieved with a 
low-pressure mercury lamp by Majetich and co-workers in 
cyclohexane, lead to the formation of komarovispirone (3) as the 
sole product.[10] However, under sunlight irradiation, the 
formation of an additional unknown compound in a CDCl3 
solution was reported. This by-product could correspond to 
cyclocoulterone (1), but no analytical data was reported[10] to 
verify this hypothesis. 
A possible mechanism to rationalize the formation of 
cyclocoulterone (1), in accordance with the suggested proposal 
for the formation of komarovispirone, [10] is depicted in Scheme 7. 
Light excitation of the n → π* transition of the quinone 2 could 
generate the quinol diradical A that could undergo a 1,5 H-atom 
transfer (HAT) between the alkoxy radical at C14 and the 
hydroxyl group at C7 to give B. At this point, the compound B 
could either fragment at the C6-C7 bond to form the biradical C, 
which recombined to komarovispirone (3), or at the C7 O(C10) 
ether bond, which after successive 1,5 and 1,6 HAT respectively, 
recombine to yield cyclocoulterone (1). 
 
 
 
 
 
 
 
 
 
Scheme 7. Proposed mechanism for the co-formation of cyclocoulterone (1) 
and komarovispirone (3) through the photolysis of komaroviquinone (2). 
 
Model substrate synthesis and photolysis.  
 
The generality of this reaction was investigated by using a non-
natural model substrate. The synthesis of fully substituted 
quinone 23 (Scheme 8) was therefore engaged starting with the 
1,2,4-trimethoxy-3-isopropyl benzene (24), which was obtained 
via known procedures from the commercially available 25 in two 
steps in 45% overall yield. [32] Rieche formylation of 24 yielded 
aldehyde 26 in an excellent yield of 96%. The C=O group of 26 
was reduced using Pd(OH)2/C in methanol under H2 pressure 
(80 bar) and the electron rich methylphenyl 27 was obtained in 
good yield (77%). The same formylation and reduction sequence 
then furnished the hexasubstituted benzene 28, via aldehyde 29, 
in a good overall yield of 84%. Silver(II) oxide demethylative 
oxidation of catechol 28 succeeded to provide the quinone 23 in 
good yield (62%). Having this model system in hand, the remote 
C−H functionalization was explored with quinone 23. Applying 
the conditions developed earlier (direct sunlight, Et2O, rt) led to a 
full conversion of the starting material (observed by decoloration 
of the reaction mixture and confirmed by TLC analysis), however, 
without formation of the desired methylenedioxy bridge. Different 
solvents (benzene, t-BuOH, CHCl3) and light sources (sunlight, 
medium pressure mercury lamp) were evaluated next. 
Photolysis of 23 in t-BuOH was effective and resulted in the 
formation of the desired compound featuring the methylenedioxy 
bridge 30 in 47% yield using a medium pressure Hg lamp at 
room temperature. The feasibility of this reaction in t-BuOH 
rather than in Et2O could be explained by the higher ability of 
t-BuOH to form hydrogen bonds with a phenolxyl radical and 
stabilizea putative biradical species, which would favor the 
formation of the methylenedioxy bridge 30. 
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Scheme 8. Synthesis of model substrate 23 and its photolysis: a) Ref.[32], 
45% over 2 steps; b) TiCl4, CH2Cl2, Cl2CHOMe, −10 °C to rt, 2 h, 96%; c) 
Pd(OH)2/C, MeOH, H2 (80 bar), 24 h, 77%; d) TiCl4, CH2Cl2, Cl2CHOMe, 
−10 °C to rt, 12 h, 98%; e) Pd(OH)2/C, MeOH, H2 (80 bar), 18 h, 86%; f) AgO, 
HNO3, (6 M), dioxane, rt, 80 min, 62%; g) Medium pressure Hg-lamp, t-BuOH, 
45 min, rt, 47%. 
 
Synthesis of members of the barbatusol class. 
 
Having salvicanol (12) in hand, syntheses of several barbatusol 
natural products[11] were investigated (Scheme 9). A 
demethylative oxidation of salvicanol (12) using DDQ in aqueous 
acetone generated the orthoquinone 31 in excellent yield (96%), 
after aqueous workup. [24], [33] However, purification by silica was 
difficult, as 31 was reacting further. Therefore, we investigated 
the outcome of a prolonged exposure of orthoquinone 31 on 
silica gel upon adsorption. The quinone 31 was dissolved in 
ether, adsorbed on silica, with subsequent removal of the 
solvent. After 48 h at rt, this impregnated silica was 
subsequently purified by flash chromatography on silica gel to 
afford two main products, identified as przewalskin E (32) and 
brussonol (33). Interestingly, when the adsorbed orthoquinone 
(31) was left in an open flask with frequent mixing of the 
impregnated silica powder (every 4 hours), a higher yield of 
oxidized przewalskin E (32, 50%) was obtained without 
detectable formation of brussonol (33). 
 
 
Scheme 9. Synthesis of przewalskin E (32), brussonol (33) and first synthesis 
of obtusinones D (34) and E (35): a) DDQ, aq. acetone, rt, 10 min., 96%; b) 
SiO2, 48 h, 39–50% (2 steps); c) Na2S2O4 (aq.), Et2O, 1 min, 94%; d) DDQ, 
dioxane, 80% e) Neat, 100 °C, 6 h, 69%. 
 
The outcome of this reaction could be rationalized by a silica gel 
acid catalyzed tautomerization (Scheme 10), forming a reactive  
quinone-methide intermediate, which upon nucleophilic attack of 
the angular C10-OH group could result in brussonol (33). Upon 
aerobic conditions, 33 can be further converted into its natural 
congener przewalskin E (32). Majetich and co-workers already 
reported such a synthesis of brussonol (33) from 31 through 
heating a concentrated solution of 31 in Et2O (60 °C, 40 h, 
70%).[24] Similarly, Takeya and co-workers described the same 
transformation by heating 31, adsorbed on magnesium silicates 
(Florisil®) in a microwave oven (150 °C, 5 min, 37%).[33b] 
However, none of these methods were suitable to produce 
przewalskin E (32) directly from 31. Interestingly, only very few 
reports of catechol oxidation to orthoquinone mediated on silica 
gel under aerobic conditions are described. Futhermore, the 
crucial role of silica gel was further substantiated by experiments, 
when an acetonitrile or acetone solution of brussonol was stirred 
under oxygen atmosphere, and only trace amounts of 
przewalskin E (32) could be obtained after several days. 
 
 
Scheme 10. Mechanistic proposal for the formation brussunol (33) und 
przewalskin E (32). 
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Synthesis of the proposed structure 32 of przewalskin E 
and a proposal for revision of its constitution. 
 
Formation of such a reactive quinone methide from 
orthoquinone 31 and aerobic catechol oxidation under 
comparable reaction conditions were already reported by Burnell 
and co-workers. [35] Brussonol (33) was first isolated from Salvia 
brussonetii and shows insecticidal and anti-P388 leukemia cell 
acitivity. The spectral data of 33 were in good agreement with 
those reported for the natural and synthetic products. [13]c, [33]b 
The spectral data quinone 32, first synthetically prepared from 
natural demethylsalvicanol, [33]b and subsequently isolated from 
Salvia przewalskii MAXIM, [36] corresponds perfectly to the 
synthetic material, but significantly deviates from the natural 
sample. Although the 13C-NMR chemical shifts (0.1-0.4 ppm) 
and the optical activity of the isolated sample reasonably 
matches with our synthetic substance, the 1H-NMR chemical 
shifts (0.01-0.08 ppm) and FT-IR absorption bands (the main 
signal at 1660 cm-1 was not reported, and signals at 1722, and 
1680 cm-1 were found with much lower intensity) significantly 
diverges from the synthetic samples. Moreover, the natural 
compound was isolated as a white powder and our synthetic 
sample as a red amorphous solid, the typical color of 
orthoquinones. Unfortunately, the authors did not compare their 
sample with the synthetic compound of Takeya. [33b] However, 
the structure of 32 could be verified by interconverting it to 
brussonol (33) by reduction with aqueous Na2S2O4 in excellent 
yield (94%). The resulting 33 was then oxidized back to 32 
following the Takeya protocol (DDQ, dioxane).[33]b As the 
preparation of the proposed structure of 32 resulted in non-
identity to the natural product as judged by different data, we 
propose that a structural reassignment of przewalskin E is 
necessary. 
 
Synthesis of the proposed structure dimeric C40 terpenes 
obtusinone D and E. Reassignment of the configuration of 
obtusinone D.  
 
Having strong experimental evidence for the structure of 
synthetic 32 (via reduction to known brussonol (33) and 
subsequent re-oxidation), the synthesis of the unusual dimeric 
icetexanes obtusinones D (34) and E (35) was addressed next 
(Scheme 9). The first reported example of such an icetexane 
dimer was grandione, which was isolated by Riccio et al. in 1999 
from Toreya grandis[37] and synthesized by Takeya and 
co-workers in 2005 (and the structure was reassigned) [38] via a 
solid state hetero-Diels-Alder dimerization of orthoquinone 31. 
Obtusinone D (34) and E (35), which were recently isolated by 
Salae and Boonnak, were suggested to biogenetically originate 
from a similar Diels-Alder dimerization of przewalskin E (32). [39] 
Having 32 in hand, modified Takeya conditions (neat, 100 °C, 6 
h) were applied to achieve the first synthesis of both obtusinone 
D (34) and E (35) (1.7 : 1.0), in high overall yield (69%). The 
separation of both synthesized natural products proved to be 
difficult, using either flash chromatography or preparative TLC 
on silica gel utilizing the eluent reported in the isolation study. [39] 
We expected that the π-stacking of both natural products could 
be responsible for the identical retention time. Consequently, we 
decided to change our eluent system by adding toluene to our 
solvent mixture in order to break the π-stacking interaction 
between 34 and 35. Gratifyingly, the synthetic compounds were 
then successfully separated by preparative TLC with an 
optimized eluent (pentane/toluene/Et2O, 5/5/1). The spectral 
data of both synthetic natural products was in perfect agreement 
with the natural samples. However, an X-ray analysis of a single 
crystal of obtusinone D (34, Figure 3) could be obtained and the 
structure shows an opposite C13 and C14 configuration as 
reported by Salae and Boonnak.[39] Indeed, their study 
established the C13 and C14 configurational assignment of 34 
based on a NOESY correlation between H7 and H14 and 
between H14 and Me16. The close proximity of H7 and H14 
revealed by the X-ray crystallographic analysis of 34 (Figure 3), 
could explain the NOESY correlation measured by Salae and 
Boonnak[39] between these two centers. This NOESY correlation 
was later observed by us, therefore further substantiating the 
identity of our synthetic obtusinone D to the natural product. 
 
 
 
Figure 3. X-ray crystallographic analysis of 34. Red = oxygen, grey = carbon, 
white = hydrogen. 
 
The X-ray crystallographic analysis of synthetic obtusinone D in 
combination with the matching spectral data for both natural and 
synthetic samples therefore unambiguously requires the 
structural reassignment of the natural product, which should as a 
consequence be represented by the revised structure 36 (Figure 
4, B). Consequently, the C13 and C14 configuration of 
obtusinone E is suggested to be identical with the one of 
obtusinone D, as shown for the revised structure 37 (Figure 4, 
B). 
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Figure 4. A) Originally proposed and B) revised structure of obtusinones D 
and E. 
 
The different ratio detected for the isolated natural products 
(36:37, 4:1) compared to the one obtained by synthesis (36:37, 
1.7:1.0) could be explained by the higher temperature needed to 
achieve the Diels-Alder reaction in high yield and reasonable 
reaction time in the chemical laboratory. 
Conclusions 
A divergent, elegant and short synthesis of ten members of the 
icetexane family of natural products was achieved in four to nine 
steps from abundant (+)-carnosic acid, isolated from 
Rosmarinus officinalis. Among these members, (+)-salvicanol 
(12), (−)-cyclocoulterone (1), (−)-coulterone (22), (−)-obtusinone 
D (36) and (−)-obtusinone E (37) were synthesized for the first 
time. A straightforward, inexpensive and efficient sequence, 
consisting of methylation and hydrogenation of rosemary ethanol 
extracts enriched with carnosic acid and related congeners was 
developed to obtain the desired trimethyl carnosic acid 8 in high 
yield. Salient features of the synthesis of salvicanol (12) include 
a single step biomimetic ring expansion of the abietane 9 to the 
icetexane 11, bearing an angular hydroxyl group at C10. This 
constitutes the first experimental evidence for a tertiary 
carbocation trapping such as 5 by a water molecule, and a 
selective aromatic demethylation. (+)-Salvicanol (12) was used 
as a common intermediate to synthesize: (A) (−)-brussonol (33) 
and the reported structure pf (−)-przewalskin E (32) in two steps 
via an aromatic oxidation to form the orthoquinone 31, followed 
by an aerobic silica gel based tautomerization and oxidation; (B) 
(−)-obtusinone D (36), which was structurally reassigned, and 
(−)-obtusinone E (37), through a hetero-Diels-Alder of 
(−)-przewalskin E (32); (C) (+)-komaroviquinone (2) via a 
selective benzylic oxidation and an aromatic oxidation; (D) (−)-
cyclocoulterone (1) and (+)-komarovispirone (3) by a sunlight 
photolysis of (+)-komaroviquinone (2). This result supports our 
previous biogenetic hypothesis for the non-enzymatic formation 
of methylenedioxy catechol natural products; and finally, (E) 
(−)-coulterone (22) through hydrogenation of 
(+)-komaroviquinone (2).  
 
Experimental Section 
For the details of all experiments, see the Supporting Information. 
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